Market Cap 15.77B
Revenue (ttm) 2.89B
Net Income (ttm) 492.70M
EPS (ttm) N/A
PE Ratio 31.67
Forward PE 33.58
Profit Margin 17.03%
Debt to Equity Ratio 0.08
Volume 430,000
Avg Vol 996,846
Day's Range N/A - N/A
Shares Out 71.85M
Stochastic %K 50%
Beta 1.14
Analysts Strong Sell
Price Target $293.50

Latest News on WST

West to Participate in Upcoming Investor Conferences

May 7, 2025, 4:30 PM EDT - 6 days ago

West to Participate in Upcoming Investor Conferences


Best Dividend Aristocrats For May 2025

Apr 29, 2025, 8:07 PM EDT - 14 days ago

Best Dividend Aristocrats For May 2025

ABBV ABT ADM ADP AFL ALB AMCR


West Announces Leadership Changes

Apr 24, 2025, 6:10 AM EDT - 19 days ago

West Announces Leadership Changes


West to Host First-Quarter 2025 Conference Call

Apr 10, 2025, 6:00 AM EDT - 4 weeks ago

West to Host First-Quarter 2025 Conference Call


Best Dividend Aristocrats For April 2025

Mar 31, 2025, 4:07 PM EDT - 6 weeks ago

Best Dividend Aristocrats For April 2025

ABBV ABT ADM BDX BEN BRO CAH


West Pharmaceutical: Remains A Strong Long-Term Prospect

Mar 11, 2025, 1:15 AM EDT - 2 months ago

West Pharmaceutical: Remains A Strong Long-Term Prospect


Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 2 months ago

Top 2 Health Care Stocks That May Rocket Higher This Month

AMPH


West Announces Second-Quarter Dividend

Feb 20, 2025, 4:30 PM EST - 2 months ago

West Announces Second-Quarter Dividend